Manufacturer
NOVARTIS PHARMA STEIN AG
Contents
Secukinumab
Indication
Moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy. Alone or in combination w/ methotrexate for active psoriatic arthritis in adult patients when response to previous disease-modifying anti-rheumatic drug therapy has been inadequate. Ankylosing spondylitis in adult who have responded inadequately to conventional therapy.
Instruction
Administered by subcutaneous injection
Drug interaction
Live vaccines.
NOVARTIS PHARMA STEIN AG
Contents
Secukinumab
Indication
Moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy. Alone or in combination w/ methotrexate for active psoriatic arthritis in adult patients when response to previous disease-modifying anti-rheumatic drug therapy has been inadequate. Ankylosing spondylitis in adult who have responded inadequately to conventional therapy.
Instruction
Administered by subcutaneous injection
Drug interaction
Live vaccines.
Inquiry - Cosentyx 150mg/ml solution for injection in pre-filled syringe